Elevated urinary levels of urokinase-type plasminogen activator receptor (uPAR) in pancreatic ductal adenocarcinoma identify a clinically high-risk group.

BMC Cancer · 2011 · PMC3213238 · PMID 21999221

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

At univariate Kaplan-Meier survival analysis, patients with a high urinary suPAR/creatinine level showed a trend to poorer survival (median survival of 8 months vs. 14 months of patients with low suPAR/creatinine).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.